Häring B - Search Results

1

Clinical phase I study with one-hour paclitaxel infusion.

Mross K, Hauns B, Häring B, Bauknecht T, Meerpohl HG, Unger C, Maier-Lenz H. Mross K, et al. Among authors: haring b. Ann Oncol. 1998 May;9(5):569-72. doi: 10.1023/a:1008217429971. Ann Oncol. 1998. PMID: 9653500 Free article. Clinical Trial.

2

Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer.

Hauns B, Häring B, Köhler S, Mross K, Robben-Bathe P, Unger C. Hauns B, et al. Among authors: haring b. Arzneimittelforschung. 1999 Dec;49(12):1030-4. doi: 10.1055/s-0031-1300546. Arzneimittelforschung. 1999. PMID: 10635450 Clinical Trial.

3

Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer.

Hauns B, Häring B, Köhler S, Mross K, Unger C. Hauns B, et al. Among authors: haring b. Phytother Res. 2001 Feb;15(1):34-8. doi: 10.1002/1099-1573(200102)15:1<34::aid-ptr755>3.0.co;2-2. Phytother Res. 2001. PMID: 11180520 Clinical Trial.

4

Comparison of 1-hour and 3-hours paclitaxel infusion pharmacokinetics: results from a randomized trial.

Mross K, Häring B, Holländer N, Mielke S, Behringer D, Massing U, Unger C. Mross K, et al. Among authors: haring b. Onkologie. 2002 Dec;25(6):503-8. doi: 10.1159/000068620. Onkologie. 2002. PMID: 12566894 Clinical Trial.

5

Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin.

Unger C, Häring B, Medinger M, Drevs J, Steinbild S, Kratz F, Mross K. Unger C, et al. Among authors: haring b. Clin Cancer Res. 2007 Aug 15;13(16):4858-66. doi: 10.1158/1078-0432.CCR-06-2776. Clin Cancer Res. 2007. PMID: 17699865 Free article. Clinical Trial.

6

Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.

Steinbild S, Arends J, Medinger M, Häring B, Frost A, Drevs J, Unger C, Strecker R, Hennig J, Mross K. Steinbild S, et al. Among authors: haring b. Onkologie. 2007 Dec;30(12):629-35. doi: 10.1159/000110580. Epub 2007 Nov 30. Onkologie. 2007. PMID: 18063875 Clinical Trial.

7

Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancer.

Steinbild S, Frost A, Häring B, Unger C, Mross K. Steinbild S, et al. Among authors: haring b. Onkologie. 2009 Sep;32(8-9):488-92. doi: 10.1159/000226137. Epub 2009 Jul 23. Onkologie. 2009. PMID: 19745592 Clinical Trial.

8

Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.

Unger C, Häring B, Kruse A, Thumann A, Schneider B, Clemm C, Weber B, Clevert HD, Hockertz S, Kalousek MB. Unger C, et al. Among authors: haring b. Arzneimittelforschung. 2001;51(4):332-8. doi: 10.1055/s-0031-1300046. Arzneimittelforschung. 2001. PMID: 11367875 Clinical Trial.

9

Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot study.

Hildenbrand B, Sauer B, Kalis O, Stoll C, Freudenberg MA, Niedermann G, Giesler JM, Jüttner E, Peters JH, Häring B, Leo R, Unger C, Azemar M. Hildenbrand B, et al. Among authors: haring b. Prostate. 2007 Apr 1;67(5):500-8. doi: 10.1002/pros.20539. Prostate. 2007. PMID: 17262804 Clinical Trial.

10

Atherosclerosis is an inflammatory disease: treat it as such!

Therre M, Wenzel P, Haring B. Therre M, et al. Among authors: haring b. Clin Res Cardiol. 2024 May 28. doi: 10.1007/s00392-024-02470-x. Online ahead of print. Clin Res Cardiol. 2024. PMID: 38806822 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page